Immix Biopharma
Immix Biopharma is a California based clinical-stage biopharmaceutical company that develops Tissue-Specific Therapeutics for the treatment of cancer and inflammation.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed Immix Biopharma Information
Geographic Data
Address: 11400 West Olympic Blvd
City: Los Angeles
State: CA
Zip: 90064
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$26M
Social
Metrics
3,893,668Website Global Rank
3,159Website Monthly Traffic
Twitter Followers
Description
Immix Biopharma is a California based clinical-stage biopharmaceutical company that develops Tissue-Specific Therapeutics for the treatment of cancer and inflammation.
Contact Phone:
+13106518041
Contact Email:
Immix Biopharma went public on 12/16/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/16/2021
IPO Valuation:
$38M
Ticker Symbol:
IMMX
IPO Price:
$5/share
Amount Raised:
$21M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | IPO | $25.7M |
|
8/2017 | Series A | - | 12/2019 | Venture Round | 1 | - |
Mesa Verde Venture Partners Mesa Verde Venture Partners Mesa Verde Venture Partners Mesa Verde Venture Partners |
8/2017 | Series A | - | 12/2019 | Venture Round | 1 | - |
Mesa Verde Venture Partners Mesa Verde Venture Partners Mesa Verde Venture Partners Mesa Verde Venture Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
